Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Amyris, Inc. (AMRS)  
$0.00 0.00 (0.00%) as of 4:30 Mon 5/6


Download
   
Exchange: Nasdaq Small Cap
Security Type: N/A
Shares Out: 239,210,000
Market Cap: 478.42(K)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.000001 - $1.3
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Amyris is a biotechnology company. Co. creates, manufactures and commercializes consumer products and ingredients. Co.'s ingredients and consumer products are powered by its fermentation-based Lab-to-Market™ technology platform. Co. has produced a renewable farnesene brand, Biofene®, a long-chain, branched hydrocarbon molecule that Co. manufactures through fermentation using engineered microbes. Co. has formulated its fermentation-based ingredients such as Squalane, Hemisqualane™, and Steviol Glycoside Rebaudioside M into its consumer brands. Co.'s consumer brands include: Biossance® clean beauty skincare, Pipette® clean baby skincare, and Purecane™ sweetener.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 17,155
Total Buy Value $0 $0 $0 $69,135
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 0 0 20,999 4,403,696
Total Sell Value $0 $0 $19,949 $15,923,478
Total People Sold 0 0 1 6
Total Sell Transactions 0 0 1 15
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 402
  Page 6 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Eykerman Philip Director   –       •      –    2019-10-23 4 A $0.00 $0 D/D 2,266 7,665     -
   Piwnica Carole Director   –       •      –    2019-10-23 4 A $0.00 $0 D/D 2,266 7,798     -
   Yang Patrick Y Director   –       •      –    2019-10-23 4 A $0.00 $0 D/D 2,266 54,198     -
   Alvarez Eduardo Chief Operating Officer   •       –      –    2019-10-01 4 D $4.69 $473,390 D/D (100,936) 235,940     -
   Kung Frank Director   –       •      –    2019-08-01 4 A $0.00 $0 I/I 2,266 2,933     -
   Kung Frank Director   –       •      –    2019-08-01 4 D $0.00 $0 D/D (2,266) 1,333     -
   Kelsey Nicole General Counsel and Secretary   •       –      –    2019-08-01 4 D $2.93 $7,091 D/D (2,420) 104,634     -
   Melo John President and CEO   •       •      –    2019-07-01 4 D $3.65 $261,585 D/D (71,667) 694,882     -
   Hughes Anthony Chief Accounting Officer   •       –      –    2019-06-01 4 D $3.39 $21,832 D/D (6,440) 49,435     -
   Mccann James F Director   –       •      –    2019-05-20 4 A $0.00 $0 D/D 490 490     -
   Doerr L John Director   –       •       •   2019-05-14 4 A $4.60 $5,163,316 I/I 1,122,460 18,540,044     -
   Melo John President and CEO   •       •      –    2019-05-01 4 D $4.05 $62,042 D/D (15,319) 766,549     -
   Kelsey Nicole General Counsel and Secretary   •       –      –    2019-05-01 4 D $4.05 $46,680 D/D (11,526) 107,054     -
   Valiasek Kathleen Chief Financial Officer   •       –      –    2019-05-01 4 D $4.05 $95,540 D/D (23,590) 226,523     -
   Cherry Joel President of R&D   •       –      –    2019-05-01 4 D $4.05 $116,964 D/D (28,880) 241,417     -
   Kung Frank Director   –       •      –    2019-04-29 4 B $4.76 $4,348,398 I/I 913,529 787,259 2.1     -
   Doerr L John Director   –       •       •   2019-04-24 4 B $5.12 $14,502,093 I/I 2,832,440 17,417,584 2.25     -
   Doerr L John Director   –       •       •   2019-04-15 4 B $2.87 $19,321,899 I/I 6,732,369 14,585,144 2.25     -
   Melo John President and CEO   •       •      –    2019-01-14 4 A $0.00 $0 D/D 38,616 781,868     -
   Valiasek Kathleen Chief Financial Officer   •       –      –    2019-01-02 4 D $3.34 $5,067 D/D (1,517) 250,113     -
   Alvarez Eduardo Chief Operating Officer   •       –      –    2018-12-13 4 B $4.23 $50,058 D/D 11,834 333,876 2.74     -
   Valiasek Kathleen Chief Financial Officer   •       –      –    2018-11-27 4 B $4.37 $100,574 D/D 23,000 251,630 2.74     -
   Koninklijke Dsm N.v.   •       •       •   2018-11-19 4 OE $0.00 $1,619 I/I 2,678,402 13,007,353     -
   Koninklijke Dsm N.v.   •       •       •   2018-11-19 4 A $0.00 $0 I/I 1,643,991 10,328,951     -
   Total Raffinage Chimie Director by Deputization   –       •       •   2018-11-08 4 OE $4.40 $9,794,862 D/D 2,226,105 9,953,472     -

  402 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed